Florence Abravanel Selected Research

Florence Abravanel Research Topics

Disease

48	Infections 11/2022 - 02/2008
15	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 02/2008
10	Persistent Infection 01/2021 - 09/2012
10	Virus Diseases (Viral Diseases) 07/2020 - 03/2010
8	Hepatitis E 11/2022 - 04/2010
5	Hepatitis 09/2019 - 11/2004
4	COVID-19 01/2022 - 01/2020
4	Neoplasms (Cancer) 09/2019 - 08/2015
4	Viremia 01/2017 - 01/2013
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2014
2	Hepatitis C 08/2019 - 01/2018
2	Cryoglobulinemia 12/2018 - 04/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2014 - 01/2012
2	Anemia 03/2014 - 11/2010
2	Chronic Disease (Chronic Diseases) 02/2010 - 02/2008
1	Liver Diseases (Liver Disease) 11/2022
1	HIV Infections (HIV Infection) 01/2020
1	Fever (Fevers) 01/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2020
1	Malaria 01/2019
1	Proteinuria 01/2019
1	Yellow Fever 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Acute Disease 01/2018
1	Lymphoma (Lymphomas) 08/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2016
1	Edema (Dropsy) 04/2016
1	Hypertension (High Blood Pressure) 04/2016
1	Autoimmune Diseases (Autoimmune Disease) 03/2016
1	Arthritis (Polyarthritis) 04/2015
1	Necrosis 04/2015
1	Rheumatic Fever (Acute Articular Rheumatism) 04/2015
1	Reinfection 06/2014
1	Body Weight (Weight, Body) 03/2014
1	Fibrosis (Cirrhosis) 01/2014

Drug/Important Bio-Agent (IBA)

25	RNA (Ribonucleic Acid)IBA 11/2022 - 02/2008
21	Ribavirin (Virazole)FDA LinkGeneric 01/2021 - 11/2010
9	Immunoglobulin M (IgM)IBA 11/2022 - 12/2013
8	Antiviral Agents (Antivirals)IBA 01/2020 - 11/2010
7	Immunoglobulin G (IgG)IBA 11/2022 - 11/2004
7	EnzymesIBA 12/2019 - 02/2010
4	AntibodiesIBA 01/2022 - 11/2004
3	AntigensIBA 01/2021 - 01/2016
3	InterferonsIBA 07/2020 - 11/2010
2	Biological ProductsIBA 01/2021 - 01/2020
2	tocilizumab (atlizumab)FDA Link 01/2020 - 04/2015
2	LipidsIBA 01/2019 - 10/2017
2	SofosbuvirIBA 01/2018 - 01/2017
2	WastewaterIBA 01/2018 - 02/2016
2	Alanine Transaminase (SGPT)IBA 04/2015 - 06/2011
1	Immunoglobulins (Immunoglobulin)IBA 11/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2020
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 09/2019
1	ibrutinibIBA 09/2019
1	ZincIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Nucleic AcidsIBA 01/2019
1	Viral RNAIBA 01/2019
1	Viral AntibodiesIBA 01/2019
1	Infliximab (Remicade)FDA Link 01/2018
1	Azathioprine (Imuran)FDA LinkGeneric 01/2018
1	SuspensionsIBA 01/2017
1	daclatasvirIBA 01/2017
1	CreatinineIBA 04/2016
1	Aspartic Acid (Aspartate)FDA Link 04/2015
1	Methotrexate (Mexate)FDA LinkGeneric 04/2015
1	Abatacept (Orencia)FDA Link 04/2015
1	Rituximab (Mabthera)FDA Link 04/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2015
1	polyprolineIBA 10/2014
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 09/2014
1	telaprevirIBA 09/2014
1	Erythropoietin FDA Link 03/2014
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2013
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2012
1	CytokinesIBA 09/2012
1	Interleukin-1 (Interleukin 1)IBA 09/2012
1	ChemokinesIBA 09/2012
1	Pharmaceutical PreparationsIBA 01/2011
1	Interferon-alpha (Interferon Alfa)IBA 03/2010
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2010
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2010
1	Transaminases (Aminotransferases)IBA 02/2008

Therapy/Procedure

16	Therapeutics 11/2022 - 08/2010
6	Liver Transplantation 08/2019 - 02/2008
6	Transplantation 01/2019 - 02/2008
4	Organ Transplantation 10/2021 - 02/2010
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2014
2	Blood Transfusion (Blood Transfusions) 12/2017 - 03/2014
2	Kidney Transplantation 08/2017 - 11/2010
2	Duration of Therapy 10/2015 - 03/2014
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Retreatment 01/2018